XML 60 R13.htm IDEA: XBRL DOCUMENT
v3.20.1

Accrued Expenses | 12 Months Ended
--- | ---
Dec. 31, 2019
Accrued Liabilities, Current [Abstract] |
Accrued Expenses | Accrued Expenses Accrued Expenses are as follows:
| As of December 31, |  |
| 2019 |  | 2018
Accrued expenses: |  |  |
Research and development | $ | 271,322 |  |  | $ | 705,436 |
Clinical | 421,788 |  |  | 469,473 |
Consulting | 98,245 |  |  | 86,619 |
Employee-related | 624,420 |  |  | 123,372 |
Legal | 819,323 |  |  | 15,400 |
Other | 34,947 |  |  |  | 2,450 |
Total accrued expenses | $ | 2,270,045 |  |  |  | $ | 1,402,750 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration